QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CAI

QT70Caris Life Sciences, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
18.47
+0.61+3.42%
OverviewShort InterestFilings
CAIQT70Caris Life Sciences, Inc.·NASDAQ
OverviewShort InterestFilings
18.47+3.42%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E148.51EPS (ttm)
-1.51
Insider Own2.63%
Shs Outstand282.68M
Perf Week2.61%
Market Cap5.05BForward P/E51.77EPS next Y0.36Insider Trans0.01%Shs Float-Perf Month23.46%
Enterprise Value4.66BPEG-EPS next Q-0.01Inst Own-Short Float-Perf Quarter-1.81%
Income33.83MP/S5.56EPS this Y108.81%Inst Trans-Short Ratio-Perf Half Y-33.08%
Sales907.29MP/B8.50EPS next Y168.04%ROA2.92%Short Interest-Perf YTD-31.54%
Book/sh2.10P/C34.24EPS next 5Y72.31%ROE6.47%52W High42.50 -56.54%Perf Year-
Cash/sh2.91P/FCF40.89EPS past 3/5Y-ROIC14.09%52W Low14.19 30.16%Perf 3Y-
Dividend Est.-EV/EBITDA44.59Sales past 3/5Y46.55% 22.53%Gross Margin68.72%Volatility2.70% 4.17%Perf 5Y-
Dividend TTM-EV/Sales5.13EPS Y/Y TTM-Oper. Margin15.91%ATR (14)1.04Perf 10Y-
Dividend Ex-Date-Quick Ratio7.05Sales Y/Y TTM120.15%Profit Margin3.75%RSI (14)58.89Recom2.50
Dividend Gr. 3/5Y-Current Ratio7.05EPS Q/Q250.00%SMA209.71%Beta1.51Target Price28.60
Payout0.00%Debt/Eq0.73Sales Q/Q78.51%SMA504.04%Rel Volume0.91Prev Close17.86
Employees1,769LT Debt/Eq0.66EarningsAug 11SMA200-22.70%Avg Volume2.58MPrice18.47
IPO DateJun 18, 2025Option/ShortYes / YesEPS/Sales Surpr.1500.00% 22.08%Net Debt/EBITDA-3.73Volume2,353,487Change3.42%
Analyst Ratings
DateActionAnalystRatingTarget
May-08-26ReiteratedRobert W. Baird$28 → $22
May-08-26ReiteratedBTIGBuy$45 → $32
Apr-10-26InitiatedPiper SandlerNeutral$21
Feb-17-26InitiatedBairdOutperform$26
Jan-05-26ReiteratedEvercore ISI$40 → $38
Dec-22-25ReiteratedCanaccord GenuityHold$28 → $30
Dec-02-25InitiatedCanaccordHold$28
Aug-13-25ReiteratedBTIG$38 → $45
Jul-13-25InitiatedGuggenheimBuy$32
Latest News
Jun-16-26
Jun-16-2608:32AM
Caris Life Sciences Announces Dual Listing Of Common Shares On NYSE Texas, Effective June 17Benzinga
Jun-12-26
Jun-12-2607:57AM
Caris Life Sciences: The Discount To Peers Looks Hard To IgnoreSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
FY 2017
12/31/2017
Total Revenue907812412
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A284273233
Gross Profit624539179
Selling, General and Administrative Excl. Other406392322
Research and Development8445114
Other Operating Expense-10570
Operating Income14445-257
Interest Expense575750
Unusual Expense
———
Non-Operating Income (Expense)6156-25
Net Income Before Taxes33-68-282
Income Taxes04700
Consolidated Net Income33-538-282
Net Income From Continuing Operations33-538-282
Net Income33-538-282
EPS (Recurring)-1.56-1.90-2.70
EPS (Basic, Before Extraordinaries)-1.56-1.90-2.70
EPS (Diluted)-1.51-1.90-2.70
EBITDA10511-183
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio5.7655.55—
Gross Margin68.8066.3843.45
Operating Margin15.885.54-62.38
Net Margin3.64-66.26-68.45
Shares Outstanding2831,672255
Market Capitalization5,22745,111—
Operating Lease Expense
———
Insider Trading Volume
$20.36$19.30$18.23$17.17$16.11● Close Price0.00M0.41M0.83M1.24M1.65MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Vacirca Jeff LDirectorMay 11 '26Buy16.1531,050501,42649,671May 12 12:00 AM
CASTLEMAN PETER MDirectorJan 09 '26Option Exercise18.605,00093,00018,629Jan 13 12:00 AM
Power Luke ThomasSee RemarksDec 11 '25Option Exercise2.4499,750243,390161,821Dec 12 12:00 AM
Power Luke ThomasSee RemarksDec 11 '25Sale26.5862,2501,654,46299,571Dec 12 12:00 AM
Spetzler David BaxleyPresidentNov 07 '25Buy23.854009,540460,777Nov 10 12:00 AM
Denton John RusselSee RemarksNov 07 '25Buy24.094,184100,7939,184Nov 10 12:00 AM
Sawka GaryDirectorJun 01 '21Option Exercise21.6220,000432,40033,912Jun 03 12:00 AM
Sawka GaryDirectorJun 02 '20Option Exercise13.4820,000269,60023,321Jun 04 12:00 AM
Garcia VictorPresident and CEOMay 29 '19Option Exercise5.6022,714127,19892,864Feb 24 12:00 AM
Sawka GaryDirectorMar 29 '19Sale23.2310,000232,3006,757Apr 02 12:00 AM
Sawka GaryDirectorMar 29 '19Option Exercise5.6020,000112,00016,757Apr 02 12:00 AM
Garcia VictorPresident and CEOFeb 27 '19Buy22.741002,27481,507Feb 28 12:00 AM
Garcia VictorPresident and CEOFeb 26 '19Buy22.2410,508233,69881,407Feb 28 12:00 AM
Garcia VictorPresident and CEOJun 01 '18Buy24.2510,000242,48052,882Jun 04 12:00 AM
Dennis MarvinDirectorMay 18 '18Option Exercise15.3015,000229,50011,880May 22 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR